1,068 results on '"Butler, Alexandra E."'
Search Results
2. Curcumin and Ferroptosis: a Promising Target for Disease Prevention and Treatment
3. RNA interference-based therapies for atherosclerosis: Recent advances and future prospects
4. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits
5. Impact of curcumin on p38 MAPK: therapeutic implications
6. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2
7. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets
8. Unearthing nature's remedy: An exploration into Lycopodium's medicinal and therapeutic potential
9. The effectiveness of blood glucose and blood ketone measurement in identifying significant acidosis in diabetic ketoacidosis patients
10. The interplay between androgens and the immune response in polycystic ovary syndrome
11. Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetes
12. Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease
13. Therapeutic effects of anti-diabetic drugs on traumatic brain injury
14. Regulatory effects of curcumin on nitric oxide signaling in the cardiovascular system
15. Relationship between endocrine disrupting chemicals (phthalate metabolites, triclosan and bisphenols) and vitamin D in female subjects: An exploratory pilot study
16. Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2
17. The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology, and Variants of Concern
18. Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
19. Association of flame retardants, polybrominated diethyl ethers (PBDEs), with vitamin D in female subjects
20. A Comparison of Repeat Cross-Sectional and Longitudinal Results from the COMPASS Study: Design Considerations for Analysing Surveillance Data over Time
21. Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure
22. Association of Vitamin D with Perfluorinated Alkyl Acids in Women with and without Non-Obese Polycystic Ovary Syndrome
23. Effect of Hypoglycemia and Rebound Hyperglycemia on Proteomic Cardiovascular Risk Biomarkers
24. Pregnancy in human IAPP transgenic mice recapitulates beta cell stress in type 2 diabetes
25. In the setting of β-cell stress, the pancreatic duct gland transcriptome shows characteristics of an activated regenerative response
26. The severity and duration of Hypoglycemia affect platelet-derived protein responses in Caucasians
27. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications
28. In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis
29. Dysregulation of cholesterol homeostasis is an early signal of β-cell proteotoxicity characteristic of type 2 diabetes.
30. The role of natural products as PCSK9 modulators: A review.
31. An Increase in Chromogranin Positive Hormone Negative Endocrine Cells in Pancreas in Cystic Fibrosis
32. An Increase in Chromogranin A-Positive, Hormone-Negative Endocrine Cells in Pancreas in Cystic Fibrosis.
33. Increased Chromogranin A–Positive Hormone-Negative Cells in Chronic Pancreatitis
34. Cell cycle–related metabolism and mitochondrial dynamics in a replication-competent pancreatic beta-cell line
35. Hypoglycemia-induced changes in complement pathways in type 2 diabetes
36. Distinguishing between type 1 and type 2 diabetes
37. Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes.
38. Pancreatic Nonhormone Expressing Endocrine Cells in Children With Type 1 Diabetes
39. Pancreatic Nonhormone Expressing Endocrine Cells in Children With Type 1 Diabetes.
40. Down Syndrome-Associated Diabetes Is Not Due To a Congenital Deficiency in β Cells.
41. Increased Proliferation of the Pancreatic Duct Gland Compartment in Type 1 Diabetes.
42. β Cell–specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity
43. Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications
44. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
45. A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome.
46. Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection?
47. A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome
48. Increased Frequency of Hormone Negative and Polyhormonal Endocrine Cells in Lean Individuals With Type 2 Diabetes
49. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
50. Recovery of high-quality RNA from laser capture microdissected human and rodent pancreas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.